Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Grifols Says At End June 2024, Considering SRAAS Proceeds, Leverage Ratio Is Expected To Reach 5.4x Vs. 6.8x In March 2024; FCF In Q2 2024 Expected To Be Positive, Contributing To Reach €5 Million FY24 Guidance, Which Includes €480 Million Of Extraordinary Items; By End June, Liquidity Will Stand At More Than €2.4 Billion Including SRAAS Proceeds; Is Completely Separate Entity From Scranton, And None Of Scranton's Liabilities Are Consolidated At Co's Group

Author: Benzinga Newsdesk | June 27, 2024 12:37pm

- Reuters

Posted In: GRFS

07/01/2024 Equinix, Inc. (EQIX)

07/02/2024 Intel Corporation (INTC)

07/05/2024 AXT, Inc. (AXTI)

07/05/2024 Altimmune, Inc. (ALT)

07/09/2024 Li Auto Inc. (LI)

07/12/2024 Inari Medical, Inc. (NARI)

07/12/2024 Sprout Social, Inc. (SPT)